Understanding Access Barriers to Lung Cancer Screening in Rural Populations

Sponsor
Dartmouth-Hitchcock Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT04926662
Collaborator
(none)
320
1
70.6
4.5

Study Details

Study Description

Brief Summary

The purpose of this study is to research patient preferences for lung cancer screening and pilot mobile units to address the barrier of access that decreases participation in lung cancer screening.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The overarching goal of this study is to research patient preferences for lung cancer screening and pilot mobile units to address the barrier of access that decreases participation in lung cancer screening. To facilitate this, the investigators will evaluate the feasibility of mobile lung cancer screening clinics to improve access through focus group study in designated rural areas of New Hampshire and Vermont, canvas and survey these areas to confirm need, and pilot the mobile lung cancer screening clinic to establish practicability. Findings from the proposed project will be used as preliminary data to apply for further funding and to implement the mobile unit in these identified rural communities on a consistent basis.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    320 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Understanding Access Barriers to Lung Cancer Screening in Rural Populations
    Actual Study Start Date :
    Jul 14, 2021
    Anticipated Primary Completion Date :
    Jan 1, 2027
    Anticipated Study Completion Date :
    Jun 1, 2027

    Arms and Interventions

    Arm Intervention/Treatment
    Aim 1: Focus Groups

    Focus groups will be conducted in 2 New Hampshire and 2 Vermont towns to better understand patient knowledge, attitudes, and preferences regarding access to lung cancer screening.

    Aim 2: Cross Sectional Survey

    Based on focus group feedback, the investigators will visit each proposed site to survey on 2 separate dates to confirm days and times of high traffic. The investigators will also survey patrons at the proposed locations to further determine prospective patient mobile screening preferences and evaluate willingness to participate in screening.

    Aim 3: Survey with follow up data

    The investigators will pilot mobile lung cancer screening clinics at each chosen location using the knowledge acquired from focus group experience and local patient survey. Surveys will be conducted at these clinics, and patients will be followed for up to 5 years.

    Outcome Measures

    Primary Outcome Measures

    1. Recruitment [6 months after starting the mobile lung cancer screening units (Aim 3)]

      Number of individuals recruited to the mobile lung cancer screening units

    Secondary Outcome Measures

    1. Change in knowledge [6 months after starting the mobile lung cancer screening units (Aim 3)]

      Change in knowledge before and after entering the mobile lung cancer screening, as determined by the pre and post survey

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    50 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Adults age 50 to 80 years old

    • 20 pack-year smoking history who are currently smoking or have quit smoking within the last 15 years

    Exclusion Criteria:

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Dartmouth-Hitchcock Medical Center Lebanon Ohio United States 03755

    Sponsors and Collaborators

    • Dartmouth-Hitchcock Medical Center

    Investigators

    • Principal Investigator: Rian Hasson, MD, Dartmouth-Hitchcock Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Rian M. Hasson, Staff Physician, Thoracic Surgery, Dartmouth-Hitchcock Medical Center
    ClinicalTrials.gov Identifier:
    NCT04926662
    Other Study ID Numbers:
    • D21031
    First Posted:
    Jun 15, 2021
    Last Update Posted:
    Aug 12, 2022
    Last Verified:
    Aug 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 12, 2022